When:
Monday, March 25, 2024
3:00 PM - 4:00 PM CT
Where: Ward Building, 5-230, 303 E. Chicago Avenue, Chicago, IL 60611 map it
Audience: Faculty/Staff - Student - Post Docs/Docs - Graduate Students
Contact:
Melissa Daley
Group: Department of Pharmacology Seminars
Category: Lectures & Meetings
Assessing preclinical data before dosing humans for the first time
The talk will discuss how one reviews pharmacodynamic, pharmacokinetic, and safety data to assess potential risks and benefits, a process that occurs before one decides to administer a medicinal product to humans for the first time. Included will be methods to mitigate potential risks in clinical studies. The talk will not discuss formulation or commercial issues.
Peter Pertel, PhD, MPH, Former head of translational medicine in respiratory and infectious diseases, Novartis Institute for BioMedical Research (NIBR)